Hot stocks: Brokerage view on Hindalco, Hero Motocorp, Max Financial, Apollo Hospitals and Nykaa
Hindalco and Apollo Hospitals while Goldman Sachs has a sell rating on Hero Motocorp. Jefferies and Investec have a buy rating on Max Financial and Nykaa respectively.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
JP Morgan on Hindalco: Overweight| Target price: Rs 725
JP Morgan has maintained an overweight call on Hindalco with a target price of Rs 725.
EBITDA beat in India business and three upstream projects on the anvil. JP Morgan believes these expansions will not come at the cost of balance sheet health. Q2FY25 should see a softer EBITDA/t due to a decline in LME prices.
Goldman Sachs on Hero Motocorp: Sell| Target price: Rs 4,250
Goldman Sachs maintained a sell view on the stock with a target price of Rs 4,250.
Q1 was a miss as revenue/EBITDA were 3%/5% below. Q1 ASP was down 3% QoQ, potentially indicating some level of discounting due to channel inventory build-up. Goldman Sachs sees some risk to Hero's volume trajectory.
Jefferies on Max Financial: Buy| Target price: Rs 1,220
Jefferies has maintained a buy rating with a target price of Rs 1220.
The company’s VNB was a miss on a weaker mix of premiums. A weaker mix of premiums, led by a doubling of Ulips, and share rose to 39%. The global brokerage firm expects a mix of premium to normalise as sales through banca and ecom are managed better.
JP Morgan on Apollo Hospitals: Overweight| Target price: Rs 6,800
JP Morgan maintained its overweight rating on the stock with a target price of Rs
